Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01865825 · ClinicalTrials.gov registry record

Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
20
Enrollment target

NCT01865825: Completed study, sponsored by Mayo Clinic.

NCT01865825 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01865825 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The investigators would like to determine if there are patients with PPI responsive Eosinophilic Esophagitis Infiltration that have significant loss of esophageal distensibility suggestive of esophageal fibrosis typical of classic Eosniophilic Esophagitis. If this group of patients exists, the investigators would like to determine if they have the typical endoscopic features of EoE rather than those of GERD.

Primary Outcome

We will evaluate endoscopic features of Gastroesophageal Reflux Disease(GERD) by reviewing endoscopic reports and images. The presence of esophageal narrowing, furrows, rings, fragility, and white spots will be noted form the endoscopic reports prior to the initiation of the Provation report system. We will review the endoscopic reports and the endoscopic photographs on those patients evaluated after the Provation report system was initiated. All images will be reviewed by one investigator unawa

Interventions

  • RADIATION Esophageal Barium Xray

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-03
Est. Completion 2017-03
Mayo Clinic

2,844 total trials

What the finished NCT01865825 record still lists

NCT01865825 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Esophageal Barium Xray is the first listed.

NCT01865825 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01865825 about?

NCT01865825 is a clinical study titled "Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?". The investigators would like to determine if there are patients with PPI responsive Eosinophilic Esophagitis Infiltration that have significant loss of esophageal distensibility suggestive of esophageal fibrosis typical of classic Eosniophilic Esophagitis. If this group of patients exists, the inve...

What is the current status of trial NCT01865825?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2013-03. Estimated completion is 2017-03.

What interventions are being tested in trial NCT01865825?

The interventions under investigation include: Esophageal Barium Xray (RADIATION).

Who is sponsoring clinical trial NCT01865825?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01865825, the US trial registry maintained by the National Library of Medicine. NCT01865825 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.